Friday, July 10, 2026

Drug profile · INN

epoetin delta

epoetin delta (DYNEPO) is a erythropoietin receptor agonist.

EMA: withdrawn Blood and blood forming organs (B03) B03XA
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — epoetin delta
Class
Blood and blood forming organs (B03)
Route
Patents
0
Programs
2
Data quality
0.83

Quick answer

epoetin delta (DYNEPO) is a erythropoietin receptor agonist.

Key facts

INN epoetin delta
Brand DYNEPO
Mechanism Erythropoietin receptor agonist
Target Erythropoietin receptor
Therapeutic class Blood and blood forming organs (B03)
ATC code B03XA

Mechanism of action

Erythropoietin receptor agonist

Primary target: Erythropoietin receptor

Approval history

Authority Status Date
EMA withdrawn

Pipeline programs

  1. Dynepo (Epoetin delta) Phase 3 · Takeda · Anemia
  2. Dynepo Approved · Takeda · Anemia

Related & competitor drugs

  1. apixaban Blood and blood forming organs (B01)
  2. berotralstat Blood and blood forming organs (B06)
  3. bivalirudin Blood and blood forming organs (B01)
  4. c1 inhibitor (human) Blood and blood forming organs (B06)
  5. clopidogrel Blood and blood forming organs (B01)
  6. dabigatran etexilate Blood and blood forming organs (B01)

Frequently asked questions

What is epoetin delta?

epoetin delta (DYNEPO) is a erythropoietin receptor agonist.

What is the brand name for epoetin delta?

DYNEPO is a marketed brand name for epoetin delta. Check FDA Drugs@FDA for the current US label holder and prescribing information.